秦蕾蕾,刘夫玲,周占宇,黄新刚. IgG4相关性眼眶病一例[J]. 中华眼视光学与视觉科学杂志, 2017, 19(4): 247-250.
QIN Leilei, LIU Fuling,ZHOU Zhanyu,HUANG Xingang. A case of IgG4-related orbital disease247. Chinese Journal of Optometry Ophthalmology and Visual science, 2017, 19(4): 247-250. DOI: DOI:10.3760/cma.j.issn.1674-845X.2017.04.010
Andrew N, Kearney D, Selva D. IgG4-related orbital disease: a meta-analysis and review[J]. Acta Ophthalmol, 2013, 91(8): 694- 700. DOI: 10.1111/j.1755-3768.2012.02526.x.
[2]
Berry-Brincat A, Rose GE. Idiopathic orbital inflammation: a new dimension with the discovery of immunoglobulin G4-related disease[J]. Curr Opin Ophthalmol, 2012, 23(5): 415-419. DOI: 10.1097/ICU.0b013e32835563ec.
[3]
Takahira M, Kawano M, Zen Y, et al. IgG4-related chronic sclerosing dacryoadenitis[J]. Arch Ophthalmol, 2007, 125(11):1575-1578. DOI: 10.1001/archopht.125.11.1575.
[4]
Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details[J]. Mod Rheumatol, 2012, 22(1): 1-14. DOI: 10.1007/s10165- 011-0508-6.
[5]
Kamisawa T, Okamoto A. IgG4-related sclerosing disease[J]. World J Gastroenterol, 2008, 14(25): 3948-3955.
[6]
Carruthers MN, Stone JH, Khosroshahi A. The latest on IgG4-RD: a rapidly emerging disease[J]. Curr Opin Rheumatol, 2012, 24(1): 60-69. DOI: 10.1097/BOR.0b013e32834ddb4a.
[7]
Hamano H, Arakura N, Muraki T, et al. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis[J]. J Gastroenterol, 2006, 41(12): 1197-1205. DOI: 10.1007/s00535-006-1908-9.
Ebbo M, Daniel L, Pavic M, et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry[J]. Medicine (Baltimore), 2012, 91(1): 49- 56. DOI: 10.1097/MD.0b013e3182433d77.
[10]
Sato Y, Ohshima K, Ichimura K, et al. Ocular adnexal IgG4- related disease has uniform clinicopathology[J]. Pathol Int, 2008, 58(8): 465-470. DOI: 10.1111/j.1440-1827.2008.02257.x.
Plaza JA, Garrity JA, Dogan A, et al. Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease[J]. Arch Ophthalmol, 2011, 129(4): 421-428. DOI: 10. 1001/archophthalmol.2011.16.
[13]
Sato Y, Notohara K, Kojima M, et al. IgG4-related disease: historical overview and pathology of hematological disorders[J]. Pathol Int, 2010, 60(4): 247-258. DOI: 10.1111/j.1440-1827. 2010.02524.x.
[14]
Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011[J]. Mod Rheumatol, 2012, 22(1): 21-30. DOI: 10.1007/s10165-011- 0571-z.
[15]
McNab AA, McKelvie P. IgG4-related ophthalmic disease. Part I: background and pathology[J]. Ophthal Plast Reconstr Surg, 2015, 31(2): 83-88. DOI: 10.1097/IOP.0000000000000363.
[16]
Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease[J]. Lancet, 2015, 385(9976): 1460-1471. DOI: 10.1016/S0140-6736(14)60720-0.
Yamamoto H, Yamaguchi H, Aishima S, et al. Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study[J]. Am J Surg Pathol, 2009, 33(9): 1330-1340.
[20]
Kitagawa S, Zen Y, Harada K, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Küttner′s tumor)[J]. Am J Surg Pathol, 2005, 29(6): 783-791.
[21]
Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease[J]. Am J Surg Pathol, 2010, 34(2): 202-210. DOI: 10.1097/PAS.0b0 13e3181c811ad.
[22]
Glass LR, Freitag SK. Management of orbital IgG4-related disease[J]. Curr Opin Ophthalmol, 2015, 26(6): 491-497. DOI: 10.1097/ICU.0000000000000204.
[23]
Wu A, Andrew NH, Tsirbas A, et al. Rituximab for the treatment of IgG4-related orbital disease: experience from five cases[J]. Eye (Lond), 2015, 29(1): 122-128. DOI: 10.1038/eye.2014. 251.